Assessment of Breast Cancer Response to Neoadjuvant Anthracycline-based Chemotherapy by FDG-PET and Molecular Markers

NCT02600442 · clinicaltrials.gov ↗

UNKNOWN

Status

168

Enrollment

OTHER

Sponsor class

Conditions

Breast Neoplasms
Breast Cancer

Interventions

OTHER: non interventional study

Sponsor

Assistance Publique - Hôpitaux de Paris